ABT vs CMT · P/E 25, rev $44.33B vs P/E 21, rev $121.3M
Abbott Laboratories (ABT) versus Core Molding Technologies Inc (CMT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Core Molding Technologies Inc (CMT) is a specialty chemicals company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CMT revenue for 2026-06-30 was $121.3M. Net income was $2.4M. CMT currently screens at market cap $197.6M and trailing P/E 20.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CMT currently screens at market cap $197.6M and trailing P/E 20.8.
Not investment advice. Open the ABT and CMT stock pages for the full models.
Not investment advice.